3,357 reports of this reaction
3.0% of all METFORMIN HYDROCHLORIDE reports
#3 most reported adverse reaction
NAUSEA is the #3 most commonly reported adverse reaction for METFORMIN HYDROCHLORIDE, manufactured by Santarus, Inc.. There are 3,357 FDA adverse event reports linking METFORMIN HYDROCHLORIDE to NAUSEA. This represents approximately 3.0% of all 110,881 adverse event reports for this drug.
Patients taking METFORMIN HYDROCHLORIDE who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is a less commonly reported adverse event for METFORMIN HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to nausea, the following adverse reactions have been reported for METFORMIN HYDROCHLORIDE:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 3,357 FDA reports for METFORMIN HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 3.0% of all adverse event reports for METFORMIN HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience nausea while taking METFORMIN HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.